Millstone enhances packaging services
Millstone Medical Outsourcing (Fall River, Massachusetts), a provider of outsourcing solutions to the medical device industry, said it has expanded its Contract Packaging Division through investment in four additional key assets, including a Particulate Monitoring System, a second Omni 2000 Branson Ultrasonic Cleaning system, a class 100 laminar flow hood, and Nitric Acid passivation system.
Millstone, with 4,000 square feet of Class 10,000/ISO 7 clean room operating space, said its enhanced suite of packaging services will enable it to offer clients the most advanced technology for a wider range of services and superior quality assurance. n
Hospira to expand Kansas manufacturing plant
Hospital products manufacturer Hospira (Lake Forest, Illinois) reported that it will make a $60 million investment in its McPherson, Kansas, manufacturing facility, made possible through a collaboration with the state of Kansas and the Kansas Bioscience Authority (KBA). The expansion is expected to result in around 100 more jobs at the facility in the areas of manufacturing and R&D.
The construction effort began in late 2005 and will convert about 120,000 square feet of existing space into usable offices, laboratories and manufacturing operations for injectable pharmaceuticals.
The expansion of the McPherson plant will result in an incremental $60 million being invested in the facility and is targeted for completion by early 2008. As a result, the company will expand its manufacturing capacity for existing generic injectable pharmaceuticals and make room for additional products to be manufactured at the plant in the future, including production being transferred from Hospira's North Chicago, Illinois, facility.
In association with the project, the KBA will partner with Hospira to create a scholars program at the McPherson plant, thus strengthening Hospira's relationship with local universities and also provide a more formal process for the company and Kansas public universities to work together on recruiting efforts.
Calypte notified of possible Amex delisting
Calypte Biomedical (Lake Oswego, Oregon) reported that on Feb. 14, the American Stock Exchange notified the company that it had set March 13 as the date for a hearing to review the Amex staff's determination to delist the company's common stock from trading on Amex.
Calypte had requested a hearing by a listing qualifications panel to appeal the staff's determination by letter dated Feb. 9. If its common stock is delisted from the exchange after the hearing, the company said it would likely trade on the NASD Over-the-Counter Bulletin Board.
Calypte Biomedical is developing diagnostic testing products for the detection of sexually transmitted diseases.